Esryptin Tablet 50mg (Sitagliptin Hydrochloride Monohydrate)

Adult dose

The recommended dosage of this medication is 100 mg once daily when used alone or in combination; the maximum daily dose is 100 mg. It can be taken regardless of meals. In patients with renal impairment, dosage adjustments are necessary based on renal function. No dosage adjustment is needed for patients with mild and moderate renal impairment (eGFR ≥ 45). For patients with moderate renal impairment (eGFR 30 to < 45), the dosage is 50 mg once daily.

This medication may cause allergic reactions; if symptoms such as hives, rashes, or difficulty breathing occur, immediately discontinue use and consult a physician. During treatment, serious inflammation of the pancreas known as pancreatitis may occur; seek immediate medical attention if you experience abdominal pain, vomiting, or severe discomfort. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, and use should be avoided in those with allergies to this medication or its components. Patients with decreased renal function should adjust the dosage of this medication according to their physician's instructions, and regular monitoring of renal function is important. While taking this medication, side effects such as cold symptoms, headaches, and digestive disorders may occur, particularly if taken in conjunction with insulin or sulfonylureas where hypoglycemia may occur more frequently. It is recommended that pregnant or breastfeeding women avoid this medication, and safety and efficacy have not been established in children and adolescents under 18 years old. Elderly patients may experience decreased renal function, necessitating dosage adjustments and monitoring of renal function. In case of overdose, immediate medical attention should be sought, and blood dialysis may be considered if necessary. The risk of hypoglycemia may increase when used with other blood sugar-lowering agents; adjustments to the dosage of co-administered medications may be necessary. If you experience severe joint pain or blisters on the skin, notify your physician immediately and cease use to receive professional treatment. This medication typically does not have a significant effect on cardiovascular health; however, patients with pre-existing cardiovascular conditions require regular check-ups. Discuss with your physician before and after taking this medication to confirm your health status and the interactions with other medications you are taking.

Serious side effects

• Hives
• severe swelling (angioedema)
• chest tightness
• difficulty breathing
• anaphylaxis
• Stevens-Johnson syndrome
• severe skin reaction
• acute pancreatitis
• severe hypersensitivity reaction
• severe allergic reaction

Mild side effects

• Upper respiratory infection
• nasopharyngitis
• headache
• diarrhea
• nausea
• abdominal pain
• constipation
• vomiting
• myalgia
• limb pain

This medication should be stored in a tightly sealed container to prevent air exposure, preferably at room temperature between 1°C and 30°C. Proper storage helps maintain the medication's effectiveness over time.

Appearance

Light yellow pink, round, biconvex, film-coated tablet

Package unit

30 tablets - 10 tablets/PTP[x3]